Mihael H. Polymeropoulos
Net Worth

Last updated:

What is Mihael H. Polymeropoulos net worth?

The estimated net worth of Dr. Mihael H. Polymeropoulos is at least $39,402,897 as of 5 Mar 2024. He owns shares worth $8,535,089 as insider, has earned $3,507,808 from insider trading and has received compensation worth at least $27,360,000 in Vanda Pharmaceuticals Inc..

What is the salary of Mihael H. Polymeropoulos?

Dr. Mihael H. Polymeropoulos salary is $1,440,000 per year as Founder, Pres, Chief Executive Officer & Director in Vanda Pharmaceuticals Inc..

How old is Mihael H. Polymeropoulos?

Dr. Mihael H. Polymeropoulos is 65 years old, born in 1960.

What stocks does Mihael H. Polymeropoulos currently own?

As insider, Dr. Mihael H. Polymeropoulos owns shares in one company:

Company Title Shares Price per share Total value
Vanda Pharmaceuticals Inc. (VNDA) Founder, Pres, Chief Executive Officer & Director 1,871,730 $4.56 $8,535,089

What does Vanda Pharmaceuticals Inc. do?

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

VNDA logo
VNDA
Vanda Pharmaceuticals Inc.
$4.56

Mihael H. Polymeropoulos insider trading

Vanda Pharmaceuticals Inc.

Dr. Mihael H. Polymeropoulos has made 52 insider trades between 2006-2024, according to the Form 4 filled with the SEC. Most recently he sold 24,288 units of VNDA stock worth $100,285 on 5 Mar 2024.

The largest trade he's ever made was exercising 359,815 units of VNDA stock on 22 May 2015. As of 5 Mar 2024 he still owns at least 1,871,730 units of VNDA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 24,288 $4.13 $100,285
Sale
Common Stock 30,884 $4.24 $131,072
Sale
Common Stock 22,538 $6.25 $140,885
Sale
Common Stock 22,426 $6.23 $139,714
Option
Common Stock 75,365 $3.12 $235,139
Option
Stock Option (Right to Buy) 75,365 $3.12 $235,139
Sale
Common Stock 48,250 $10.61 $512,077
Sale
Common Stock 47,650 $10.62 $506,186
Option
Common Stock 74,635 $3.12 $232,861
Option
Stock Option (Right to Buy) 74,635 $3.12 $232,861
Sale
Common Stock 29,588 $11.15 $329,936
Sale
Common Stock 7,508 $11.19 $84,015
Sale
Common Stock 46,200 $16 $739,339
Option
Employee Stock Option (Right to Buy) 78,324 $4.88 $382,221
Option
Employee Stock Option (Right to Buy) 71,676 $4.88 $349,779
Option
Common Stock 71,676 $4.88 $349,779
Sale
Common Stock 50,000 $16.49 $824,300
Option
Common Stock 78,324 $4.88 $382,221
Sale
Common Stock 175,000 N/A N/A
Sale
Common Stock 15,206 N/A N/A
Sale
Common Stock 7,479 N/A N/A
Sale
Common Stock 39,150 N/A N/A
Option
Common Stock 46,663 N/A N/A
Option
Employee Stock Option (Right to Buy) 46,663 N/A N/A
Option
Common Stock 61,520 N/A N/A
Sale
Common Stock 51,049 N/A N/A
Option
Employee Stock Option (Right to Buy) 61,520 N/A N/A
Option
Employee Stock Option (Right to Buy) 41,817 N/A N/A
Sale
Common Stock 35,053 N/A N/A
Option
Common Stock 41,817 N/A N/A
Sale
Common Stock 5,152 N/A N/A
Sale
Common Stock 10,428 N/A N/A
Sale
Common Stock 9,467 N/A N/A
Option
Common Stock 85,801 N/A N/A
Sale
Common Stock 70,036 N/A N/A
Option
Employee Stock Option (Right to Buy) 85,801 N/A N/A
Option
Common Stock 89,199 N/A N/A
Option
Employee Stock Option (Right to Buy) 89,199 N/A N/A
Sale
Common Stock 72,373 N/A N/A
Option
Common Stock 79,019 N/A N/A
Sale
Common Stock 72,872 N/A N/A
Option
Employee Stock Option (Right to Buy) 79,019 N/A N/A
Sale
Common Stock 67,418 N/A N/A
Option
Common Stock 73,608 N/A N/A
Option
Employee Stock Option (Right to Buy) 73,608 N/A N/A
Sale
Common Stock 77,225 N/A N/A
Option
Employee Stock Option (Right to Buy) 97,373 N/A N/A
Option
Common Stock 97,373 N/A N/A
Sale
Common Stock 38,166 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Sale
Common Stock 4,447 N/A N/A
Sale
Common Stock 10,789 N/A N/A
Sale
Common Stock 60,966 N/A N/A
Option
Restricted Stock Unit 31,250 N/A N/A
Option
Employee Stock Option (Right to Buy) 250,000 N/A N/A
Option
Common Stock 293,750 N/A N/A
Sale
Common Stock 191,760 N/A N/A
Option
Restricted Stock Unit 50,000 N/A N/A
Sale
Common Stock 23,330 N/A N/A
Option
Common Stock 50,000 N/A N/A
Option
Restricted Stock Unit 43,750 N/A N/A
Sale
Common Stock 21,353 N/A N/A
Option
Common Stock 43,750 N/A N/A
Sale
Common Stock 102,162 N/A N/A
Option
Common Stock 147,626 N/A N/A
Option
Employee Stock Option (Right to Buy) 147,626 N/A N/A
Option
Common Stock 42,747 N/A N/A
Option
Employee Stock Option (Right to Buy) 42,747 N/A N/A
Sale
Common Stock 29,577 N/A N/A
Option
Common Stock 359,815 N/A N/A
Sale
Common Stock 169,238 N/A N/A
Option
Employee Stock Option (Right to Buy) 359,815 N/A N/A
Option
Employee Stock Option (Right to Buy) 35,806 N/A N/A
Option
Common Stock 35,806 N/A N/A
Sale
Common Stock 17,157 N/A N/A
Option
Restricted Stock Unit 37,500 N/A N/A
Sale
Common Stock 21,900 N/A N/A
Option
Common Stock 43,750 N/A N/A
Option
Employee Stock Option (Right to Buy) 48,154 N/A N/A
Option
Common Stock 48,154 N/A N/A
Option
Restricted Stock Units 31,250 N/A N/A
Option
Restricted Stock Unit 18,750 N/A N/A
Option
Common Stock 50,000 N/A N/A
Sale
Common Stock 8,928 N/A N/A
Option
Restricted Stock Unit 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Option
Restricted Stock Unit 43,750 N/A N/A
Option
Common Stock 43,750 N/A N/A
Sale
Common Stock 11,350 N/A N/A
Option
Common Stock 31,250 N/A N/A
Option
Restricted Stock Unit 18,750 N/A N/A
Purchase
Common Stock 15,840 N/A N/A
Purchase
Common Stock 4,160 N/A N/A
Option
Common Stock 18,750 N/A N/A
Option
Restricted Stock Unit 18,750 N/A N/A
Sale
Common Stock 82,600 N/A N/A
Sale
Common Stock 17,400 N/A N/A
Option
Common Stock 75,000 N/A N/A
Option
Restricted Stock Units 75,000 N/A N/A
Option
Common Stock 75,000 N/A N/A
Option
Restricted Stock Units 75,000 N/A N/A
Purchase
Common Stock 50,000 N/A N/A
Purchase
Common Stock 118,000 N/A N/A
Purchase
Common Stock 182,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 20,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Non-Qualified Stock Option (Right to Buy) 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Option
Common Stock 150,000 N/A N/A
Option
Employee Stock Option (right to buy) 150,000 N/A N/A
Sale
Common Stock 150,000 N/A N/A
Sale
Common Stock 1,127 N/A N/A
Option
Common Stock 1,127 N/A N/A
Option
Employee Stock Option (right to buy) 1,127 N/A N/A
Option
Common Stock 16,200 N/A N/A
Sale
Common Stock 16,200 N/A N/A
Option
Employee Stock Option (right to buy) 16,200 N/A N/A

Vanda Pharmaceuticals key executives

Vanda Pharmaceuticals Inc. executives and other stock owners filed with the SEC: